Here, we showed that CML patient-derived Flk1+CD31-CD34-MSCs had normal morphology, phenotype and karyotype but appeared impaired in immuno-modulatory function. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.